Skip to main content
OpenTrials

Clinical trial condition

Bulbo-Spinal Atrophy, X-Linked

Explore clinical trials studying Bulbo-Spinal Atrophy, X-Linked. Study availability and eligibility vary by location and protocol.

40 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Bulbo-Spinal Atrophy, X-Linked trial results

Recruiting

UK SMA Patient Registry

NCT04292574

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • John Walton Muscular Dystrophy Research Centre Newcastle upon Tyne, United Kingdom
View Trial Details
Completed

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

NCT05694819

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Chiba University Hospital Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • National Hospital Organization Kyushu Medical Center Fukuoka, Japan
View Trial Details
Completed

A Study of NIDO-361 in Patients With SBMA

NCT06411912

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Rigshospitalet, Klinik for Nerve- og Muskelsygdomme & Copenhagen Neuromuscular Center Copenhagen, Denmark
  • IRCCS Istituto Neurologico Carlo Besta Milan, Italy
  • Azienda Ospedale Università di Padova Padova, Italy
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
View Trial Details
Completed

Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam

NCT05386680

Conditions
Atrophy, Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, +19 more
Locations
  • Boston Childrens Hospital Boston, Massachusetts, United States
  • Child Hosp Of The Kings Daughters Norfolk, Virginia, United States
  • University of Wisconsin Madison Medical School Madison, Wisconsin, United States
  • Novartis Investigative Site Parkville, Victoria, Australia
View all 13 locations
View Trial Details
Completed

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

NCT02294461

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • CN00103 Beijing, China
  • CN00104 Beijing, China
  • CN00106 Beijing, China
  • CN00111 Beijing, China
View all 47 locations
View Trial Details
Completed

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

NCT01969578

Conditions
Adenocarcinoma, Bulbo-Spinal Atrophy, X-Linked, Carcinoma, +22 more
Locations
  • Medical University Vienna - General Hospital AKH Vienna, Austria
  • ZNA Middelheim Antwerp, Belgium
  • Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 26 locations
View Trial Details
Completed

Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)

NCT04851873

Conditions
Atrophy, Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, +19 more
Locations
  • Novartis Investigative Site Boston, Massachusetts, United States
  • Novartis Investigative Site St Louis, Missouri, United States
  • Novartis Investigative Site Randwick, New South Wales, Australia
  • Novartis Investigative Site Leuven, Belgium
View all 13 locations
View Trial Details

Related conditions